UAB presented an observational study at this week’s annual American Society of Clinical Oncology meeting in Chicago that indicates a more rapid decline in Medicare costs and patient resource utilization during implementation of a lay navigation program.
In late March, physicians at the University of Alabama at Birmingham carefully threaded a one-way valve the size of a black-eyed pea into the lower lobe of Dennis Bullock’s left lung. Bullock, a 67-year-old emphysema patient, was the fourth person at UAB to receive the experimental Zephyr® endobronchial valve.
William C. Bailey, professor in the Division of Pulmonary, Allergy and Critical Medicine at the University of Alabama at Birmingham, has been awarded a Lifetime Achievement Award for 50 years of exemplary service by the Tulane Medical Alumni Association.
UAB and CreakyJoints, an online, non-profit, patient support community, are launching Arthritis Power — the first patient-centered research registry for arthritis, bone and inflammatory skin conditions — to securely collect health data from tens of thousands of arthritis patients to support future research.
UAB was part of a promising international study of a combination therapy for patients with the most common cystic fibrosis mutation.
Four projects were awarded through the first School of Medicine AMC21 Reload Multi-Investigator Grants, a broad funding opportunity provided through the Academic Enrichment Fund that enables faculty members to organize and integrate multi-disciplinary teams of accomplished investigators to compete successfully for long-term extramural support.
Research published in The American Journal of Medicine reports that gender disparities in income aren’t a problem just for women in medium- and lower-wage positions.
Three School of Medicine faculty members were honored last week as recipients of the 2015 UAB Graduate School Dean’s Awards for Excellence in Mentorship. 
The protective effect is achieved by reducing acute inflammation in the spleen and the left ventricle of the heart.
UAB gets $11 million grant for potential groundbreaking study of beta blockers for patients with COPD.